These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

489 related articles for article (PubMed ID: 20537753)

  • 41. Differences in long-term survival after transjugular intrahepatic portosystemic shunt for refractory ascites and variceal bleed.
    Membreno F; Baez AL; Pandula R; Walser E; Lau DT
    J Gastroenterol Hepatol; 2005 Mar; 20(3):474-81. PubMed ID: 15740494
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Long-term clinical outcome of patients with cirrhosis and refractory ascites treated with transjugular intrahepatic portosystemic shunt insertion.
    Tan HK; James PD; Sniderman KW; Wong F
    J Gastroenterol Hepatol; 2015 Feb; 30(2):389-95. PubMed ID: 25168607
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Hepatic encephalopathy after transjugular intrahepatic portosystemic shunt insertion: a decade of experience.
    Masson S; Mardini HA; Rose JD; Record CO
    QJM; 2008 Jun; 101(6):493-501. PubMed ID: 18440957
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Transjugular intrahepatic portosystemic stent shunt (TIPSS) modification in the management of post-TIPSS refractory hepatic encephalopathy.
    Kochar N; Tripathi D; Ireland H; Redhead DN; Hayes PC
    Gut; 2006 Nov; 55(11):1617-23. PubMed ID: 16571635
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Outcomes of transjugular intrahepatic portosystemic shunt using 12 mm diameter polytetrafluoroethylene covered stents in cirrhotic patients with portal hypertension.
    Habash M; Murray A; Heeke B; Mahmoud K; Li Y; Saddekni S; Abdel Aal AK; Gunn AJ
    Diagn Interv Radiol; 2022 May; 28(3):239-243. PubMed ID: 35748206
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Long-term patency and clinical outcome of the transjugular intrahepatic portosystemic shunt using the expanded polytetrafluoroethylene stent-graft.
    Luo X; Zhao M; Wang X; Jiang M; Yu J; Li X; Yang L
    PLoS One; 2019; 14(2):e0212658. PubMed ID: 30811467
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Randomized controlled study of TIPS versus paracentesis plus albumin in cirrhosis with severe ascites.
    Salerno F; Merli M; Riggio O; Cazzaniga M; Valeriano V; Pozzi M; Nicolini A; Salvatori F
    Hepatology; 2004 Sep; 40(3):629-35. PubMed ID: 15349901
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Construction of Transjugular Intrahepatic Portosystemic Shunt: Bare Metal Stent/Stent-graft Combination versus Single Stent-graft, a Prospective Randomized Controlled Study with Long-term Patency and Clinical Analysis.
    Wang CM; Li X; Fu J; Luan JY; Li TR; Zhao J; Dong GX
    Chin Med J (Engl); 2016 Jun; 129(11):1261-7. PubMed ID: 27231160
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Transjugular intrahepatic portosystemic shunt for refractory ascites: a meta-analysis of individual patient data.
    Salerno F; Cammà C; Enea M; Rössle M; Wong F
    Gastroenterology; 2007 Sep; 133(3):825-34. PubMed ID: 17678653
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Comparison of transjugular intrahepatic portosystemic shunt (TIPS) alone versus TIPS combined with embolotherapy in advanced cirrhosis: a retrospective study.
    Xiao T; Chen L; Chen W; Xu B; Long Q; Li R; Li L; Peng Z; Fang D; Wang R
    J Clin Gastroenterol; 2011 Aug; 45(7):643-50. PubMed ID: 21301360
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Transjugular intrahepatic portosystemic stent shunt: indications and long-term outcome].
    Wettstein M; Lüthen R; Cohnen M; von Wrisberg F; Mödder U; Häussinger D
    Zentralbl Chir; 2005 Jun; 130(3):246-9. PubMed ID: 15965878
    [TBL] [Abstract][Full Text] [Related]  

  • 52. TIPS: comparison of shunt patency and clinical outcomes between bare stents and expanded polytetrafluoroethylene stent-grafts.
    Jung HS; Kalva SP; Greenfield AJ; Waltman AC; Walker TG; Athanasoulis CA; Wicky ST
    J Vasc Interv Radiol; 2009 Feb; 20(2):180-5. PubMed ID: 19097918
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [The retrospective study of transjugular intrahepatic portosystemic shunt with covered or uncovered stents in patients with portal hypertension].
    Wu XJ; Cao JM; Han JM; Huang Q; Li N; Li JS
    Zhonghua Wai Ke Za Zhi; 2010 Jan; 48(2):83-7. PubMed ID: 20302722
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Transjugular intrahepatic portosystemic shunts in liver transplant recipients for management of refractory ascites: clinical outcome.
    Saad WE; Darwish WM; Davies MG; Waldman DL
    J Vasc Interv Radiol; 2010 Feb; 21(2):218-23. PubMed ID: 20123207
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Eight millimetre covered TIPS does not compromise shunt function but reduces hepatic encephalopathy in preventing variceal rebleeding.
    Wang Q; Lv Y; Bai M; Wang Z; Liu H; He C; Niu J; Guo W; Luo B; Yin Z; Bai W; Chen H; Wang E; Xia D; Li X; Yuan J; Han N; Cai H; Li T; Xie H; Xia J; Wang J; Zhang H; Wu K; Fan D; Han G
    J Hepatol; 2017 Sep; 67(3):508-516. PubMed ID: 28506905
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Portosystemic hepatic encephalopathy after transjugular intrahepatic portosystemic shunt in patients with cirrhosis: clinical, laboratory, psychometric, and electroencephalographic investigations.
    Nolte W; Wiltfang J; Schindler C; Münke H; Unterberg K; Zumhasch U; Figulla HR; Werner G; Hartmann H; Ramadori G
    Hepatology; 1998 Nov; 28(5):1215-25. PubMed ID: 9794904
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Predictors of clinical response to transjugular intrahepatic portosystemic shunt (TIPS) in cirrhotic patients with refractory ascites.
    Deschênes M; Dufresne MP; Bui B; Fenyves D; Spahr L; Roy L; Lafortune M; Pomier-Layrargues G
    Am J Gastroenterol; 1999 May; 94(5):1361-5. PubMed ID: 10235219
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Early TIPS with covered stents versus standard treatment for acute variceal bleeding in patients with advanced cirrhosis: a randomised controlled trial.
    Lv Y; Yang Z; Liu L; Li K; He C; Wang Z; Bai W; Guo W; Yu T; Yuan X; Zhang H; Xie H; Yao L; Wang J; Li T; Wang Q; Chen H; Wang E; Xia D; Luo B; Li X; Yuan J; Han N; Zhu Y; Niu J; Cai H; Xia J; Yin Z; Wu K; Fan D; Han G;
    Lancet Gastroenterol Hepatol; 2019 Aug; 4(8):587-598. PubMed ID: 31153882
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A meta-analysis of transjugular intrahepatic portosystemic shunt versus paracentesis for refractory ascites.
    Albillos A; Bañares R; González M; Catalina MV; Molinero LM
    J Hepatol; 2005 Dec; 43(6):990-6. PubMed ID: 16139922
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Feasibility and long-term evolution of TIPS in cirrhotic patients with portal thrombosis.
    Perarnau JM; Baju A; D'alteroche L; Viguier J; Ayoub J
    Eur J Gastroenterol Hepatol; 2010 Sep; 22(9):1093-8. PubMed ID: 20308910
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.